TrialAdvances in therapy2023

Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.

Rakesh K Sahay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.